The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
How to Help Your Patients Find Silenor in Stock: A Provider's Guide
A practical guide for providers on helping patients locate Silenor (doxepin) in stock — from generic substitution to pharmacy navigation to useful patient tools.
How to Help Your Patients Find Atomoxetine (Strattera) in Stock: A Provider's Guide
A practical guide for prescribers on helping ADHD patients find generic atomoxetine when pharmacies report it as out of stock in 2026.
How to Help Your Patients Find Ubrelvy in Stock: A Provider's Guide
Practical strategies for providers to help migraine patients access Ubrelvy, navigate insurance barriers, and find it in stock at nearby pharmacies.
How to Help Your Patients Find Yasmin 28 in Stock: A Provider's Guide
A practical guide for OB/GYNs, PCPs, and NPs on helping patients locate Yasmin 28 or its generics when local pharmacies are out of stock in 2026.
36,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Basaglar Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on Basaglar's 2026 availability. Covers the Semglee market exit, Tempo Pen discontinuation, switching protocols, and patient support resources.
Depakote ER Shortage: What Providers and Prescribers Need to Know in 2026
AbbVie's manufacturing delay with Depakote ER 500mg is creating real clinical challenges for providers. Here's what prescribers need to know to manage patients safely in 2026.
Doptelet Shortage: What Providers and Prescribers Need to Know in 2026
Doptelet is not in shortage, but access challenges are real. This 2026 guide helps hematologists, hepatologists, and prescribers navigate the specialty pharmacy system for their patients.
Ethinyl Estradiol/Levonorgestrel Shortage: What Providers and Prescribers Need to Know in 2026
No national FDA shortage exists for ethinyl estradiol/levonorgestrel, but your patients are still struggling to fill prescriptions. Here's what providers need to know in 2026.
Liothyronine Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on liothyronine availability in 2026, including NDT transition pressures, prescribing implications, and patient management strategies.
Myrbetriq Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for urologists, PCPs, and other prescribers on Myrbetriq (mirabegron) supply issues, step therapy changes, and patient management strategies in 2026.
Pancreaze Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Pancreaze (pancrelipase) supply and availability in 2026. Covers PERT market pressures, prescribing alternatives, and tools for providers.
Rabeprazole Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for prescribers on rabeprazole availability in 2026 — including supply status, therapeutic alternatives, patient counseling points, and formulary considerations.